nodes	percent_of_prediction	percent_of_DWPC	metapath
Nicotine—SLC22A5—dilated cardiomyopathy	0.653	1	CbGaD
Nicotine—SLC22A5—Furosemide—dilated cardiomyopathy	0.0895	0.646	CbGbCtD
Nicotine—CYP2C8—Spironolactone—dilated cardiomyopathy	0.0491	0.354	CbGbCtD
Nicotine—CYP2C9—cardial valve—dilated cardiomyopathy	0.00502	0.319	CbGeAlD
Nicotine—Local reaction—Furosemide—dilated cardiomyopathy	0.00248	0.0256	CcSEcCtD
Nicotine—Cerebration impaired—Furosemide—dilated cardiomyopathy	0.00234	0.0241	CcSEcCtD
Nicotine—Cramps of lower extremities—Spironolactone—dilated cardiomyopathy	0.00232	0.0239	CcSEcCtD
Nicotine—Apathy—Furosemide—dilated cardiomyopathy	0.00192	0.0198	CcSEcCtD
Nicotine—Blister—Furosemide—dilated cardiomyopathy	0.00191	0.0197	CcSEcCtD
Nicotine—Flat affect—Furosemide—dilated cardiomyopathy	0.00191	0.0197	CcSEcCtD
Nicotine—Sleep disturbance—Lisinopril—dilated cardiomyopathy	0.00184	0.019	CcSEcCtD
Nicotine—Disturbance in attention—Furosemide—dilated cardiomyopathy	0.00159	0.0164	CcSEcCtD
Nicotine—Heartburn—Lisinopril—dilated cardiomyopathy	0.0015	0.0155	CcSEcCtD
Nicotine—Influenza-like symptoms—Lisinopril—dilated cardiomyopathy	0.00144	0.0149	CcSEcCtD
Nicotine—Memory impairment—Lisinopril—dilated cardiomyopathy	0.00131	0.0135	CcSEcCtD
Nicotine—Rhinorrhoea—Lisinopril—dilated cardiomyopathy	0.00127	0.0131	CcSEcCtD
Nicotine—Cramps of lower extremities—Furosemide—dilated cardiomyopathy	0.00126	0.013	CcSEcCtD
Nicotine—CHRNB2—myocardium—dilated cardiomyopathy	0.00126	0.08	CbGeAlD
Nicotine—Bladder pain—Furosemide—dilated cardiomyopathy	0.00124	0.0128	CcSEcCtD
Nicotine—Mental disability—Furosemide—dilated cardiomyopathy	0.00119	0.0123	CcSEcCtD
Nicotine—Chest discomfort—Lisinopril—dilated cardiomyopathy	0.00117	0.012	CcSEcCtD
Nicotine—Muscle spasms—Spironolactone—dilated cardiomyopathy	0.00106	0.0109	CcSEcCtD
Nicotine—Dermatitis bullous—Furosemide—dilated cardiomyopathy	0.00104	0.0108	CcSEcCtD
Nicotine—Ill-defined disorder—Spironolactone—dilated cardiomyopathy	0.00103	0.0106	CcSEcCtD
Nicotine—Cystitis noninfective—Lisinopril—dilated cardiomyopathy	0.00101	0.0104	CcSEcCtD
Nicotine—Salivary hypersecretion—Lisinopril—dilated cardiomyopathy	0.001	0.0103	CcSEcCtD
Nicotine—Influenza like illness—Lisinopril—dilated cardiomyopathy	0.001	0.0103	CcSEcCtD
Nicotine—Malaise—Spironolactone—dilated cardiomyopathy	0.000996	0.0103	CcSEcCtD
Nicotine—Cystitis—Lisinopril—dilated cardiomyopathy	0.000996	0.0103	CcSEcCtD
Nicotine—Fluid retention—Lisinopril—dilated cardiomyopathy	0.000979	0.0101	CcSEcCtD
Nicotine—Irritability—Furosemide—dilated cardiomyopathy	0.000953	0.00982	CcSEcCtD
Nicotine—Bladder pain—Lisinopril—dilated cardiomyopathy	0.000933	0.00961	CcSEcCtD
Nicotine—Discomfort—Spironolactone—dilated cardiomyopathy	0.000929	0.00958	CcSEcCtD
Nicotine—Confusional state—Spironolactone—dilated cardiomyopathy	0.000909	0.00937	CcSEcCtD
Nicotine—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.000902	0.00929	CcSEcCtD
Nicotine—CHRNB2—heart—dilated cardiomyopathy	0.00088	0.0558	CbGeAlD
Nicotine—Sleep disorder—Lisinopril—dilated cardiomyopathy	0.000865	0.00892	CcSEcCtD
Nicotine—Nasal congestion—Lisinopril—dilated cardiomyopathy	0.000822	0.00847	CcSEcCtD
Nicotine—Somnolence—Spironolactone—dilated cardiomyopathy	0.000802	0.00826	CcSEcCtD
Nicotine—CHRNA2—heart—dilated cardiomyopathy	0.000793	0.0503	CbGeAlD
Nicotine—Atrial fibrillation—Lisinopril—dilated cardiomyopathy	0.00079	0.00815	CcSEcCtD
Nicotine—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.000778	0.00802	CcSEcCtD
Nicotine—Arthritis—Lisinopril—dilated cardiomyopathy	0.00077	0.00794	CcSEcCtD
Nicotine—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.000743	0.00766	CcSEcCtD
Nicotine—Urticaria—Spironolactone—dilated cardiomyopathy	0.000716	0.00738	CcSEcCtD
Nicotine—Irritability—Lisinopril—dilated cardiomyopathy	0.000715	0.00737	CcSEcCtD
Nicotine—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.000713	0.00735	CcSEcCtD
Nicotine—Nasopharyngitis—Lisinopril—dilated cardiomyopathy	0.00067	0.0069	CcSEcCtD
Nicotine—Visual impairment—Furosemide—dilated cardiomyopathy	0.000665	0.00686	CcSEcCtD
Nicotine—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.000664	0.00685	CcSEcCtD
Nicotine—Influenza—Lisinopril—dilated cardiomyopathy	0.000647	0.00667	CcSEcCtD
Nicotine—Pruritus—Spironolactone—dilated cardiomyopathy	0.000638	0.00658	CcSEcCtD
Nicotine—Bronchospasm—Lisinopril—dilated cardiomyopathy	0.000637	0.00656	CcSEcCtD
Nicotine—Sweating increased—Lisinopril—dilated cardiomyopathy	0.00063	0.0065	CcSEcCtD
Nicotine—MAOB—cardiac ventricle—dilated cardiomyopathy	0.000626	0.0397	CbGeAlD
Nicotine—Immune system disorder—Furosemide—dilated cardiomyopathy	0.000624	0.00643	CcSEcCtD
Nicotine—Bronchitis—Lisinopril—dilated cardiomyopathy	0.000622	0.00642	CcSEcCtD
Nicotine—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.000617	0.00636	CcSEcCtD
Nicotine—Arrhythmia—Furosemide—dilated cardiomyopathy	0.000617	0.00636	CcSEcCtD
Nicotine—Erythema—Furosemide—dilated cardiomyopathy	0.000601	0.0062	CcSEcCtD
Nicotine—Dizziness—Spironolactone—dilated cardiomyopathy	0.000596	0.00615	CcSEcCtD
Nicotine—Flatulence—Furosemide—dilated cardiomyopathy	0.000592	0.0061	CcSEcCtD
Nicotine—Weight increased—Lisinopril—dilated cardiomyopathy	0.000589	0.00607	CcSEcCtD
Nicotine—MAOB—myocardium—dilated cardiomyopathy	0.000589	0.0374	CbGeAlD
Nicotine—Dysgeusia—Furosemide—dilated cardiomyopathy	0.000589	0.00607	CcSEcCtD
Nicotine—Muscle spasms—Furosemide—dilated cardiomyopathy	0.000578	0.00596	CcSEcCtD
Nicotine—Vomiting—Spironolactone—dilated cardiomyopathy	0.000573	0.00591	CcSEcCtD
Nicotine—Rash—Spironolactone—dilated cardiomyopathy	0.000568	0.00586	CcSEcCtD
Nicotine—Dermatitis—Spironolactone—dilated cardiomyopathy	0.000568	0.00585	CcSEcCtD
Nicotine—Headache—Spironolactone—dilated cardiomyopathy	0.000565	0.00582	CcSEcCtD
Nicotine—CHRNA7—heart—dilated cardiomyopathy	0.000557	0.0354	CbGeAlD
Nicotine—Agitation—Furosemide—dilated cardiomyopathy	0.000552	0.00569	CcSEcCtD
Nicotine—Epistaxis—Lisinopril—dilated cardiomyopathy	0.000544	0.00561	CcSEcCtD
Nicotine—Sinusitis—Lisinopril—dilated cardiomyopathy	0.000541	0.00558	CcSEcCtD
Nicotine—Vertigo—Furosemide—dilated cardiomyopathy	0.00054	0.00557	CcSEcCtD
Nicotine—Nausea—Spironolactone—dilated cardiomyopathy	0.000536	0.00552	CcSEcCtD
Nicotine—MAOA—cardiac ventricle—dilated cardiomyopathy	0.000534	0.0339	CbGeAlD
Nicotine—Rhinitis—Lisinopril—dilated cardiomyopathy	0.000519	0.00535	CcSEcCtD
Nicotine—Pharyngitis—Lisinopril—dilated cardiomyopathy	0.000514	0.0053	CcSEcCtD
Nicotine—Oedema peripheral—Lisinopril—dilated cardiomyopathy	0.00051	0.00526	CcSEcCtD
Nicotine—MAOA—myocardium—dilated cardiomyopathy	0.000502	0.0319	CbGeAlD
Nicotine—Dry mouth—Furosemide—dilated cardiomyopathy	0.0005	0.00516	CcSEcCtD
Nicotine—Confusional state—Furosemide—dilated cardiomyopathy	0.000495	0.0051	CcSEcCtD
Nicotine—SLC22A5—cardiac ventricle—dilated cardiomyopathy	0.000492	0.0312	CbGeAlD
Nicotine—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.000491	0.00506	CcSEcCtD
Nicotine—SLC22A4—heart—dilated cardiomyopathy	0.000488	0.031	CbGeAlD
Nicotine—Shock—Furosemide—dilated cardiomyopathy	0.000483	0.00497	CcSEcCtD
Nicotine—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.000481	0.00496	CcSEcCtD
Nicotine—Flushing—Lisinopril—dilated cardiomyopathy	0.000481	0.00496	CcSEcCtD
Nicotine—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.000474	0.00489	CcSEcCtD
Nicotine—Mediastinal disorder—Lisinopril—dilated cardiomyopathy	0.000467	0.00481	CcSEcCtD
Nicotine—Arrhythmia—Lisinopril—dilated cardiomyopathy	0.000463	0.00477	CcSEcCtD
Nicotine—SLC22A5—myocardium—dilated cardiomyopathy	0.000463	0.0294	CbGeAlD
Nicotine—Hypotension—Furosemide—dilated cardiomyopathy	0.000458	0.00472	CcSEcCtD
Nicotine—Mental disorder—Lisinopril—dilated cardiomyopathy	0.000454	0.00468	CcSEcCtD
Nicotine—Erythema—Lisinopril—dilated cardiomyopathy	0.000451	0.00465	CcSEcCtD
Nicotine—Flatulence—Lisinopril—dilated cardiomyopathy	0.000444	0.00458	CcSEcCtD
Nicotine—Tension—Lisinopril—dilated cardiomyopathy	0.000443	0.00456	CcSEcCtD
Nicotine—Dysgeusia—Lisinopril—dilated cardiomyopathy	0.000442	0.00455	CcSEcCtD
Nicotine—Paraesthesia—Furosemide—dilated cardiomyopathy	0.00044	0.00454	CcSEcCtD
Nicotine—CYP1A1—cardiac ventricle—dilated cardiomyopathy	0.000439	0.0279	CbGeAlD
Nicotine—Nervousness—Lisinopril—dilated cardiomyopathy	0.000438	0.00451	CcSEcCtD
Nicotine—Back pain—Lisinopril—dilated cardiomyopathy	0.000436	0.0045	CcSEcCtD
Nicotine—Somnolence—Furosemide—dilated cardiomyopathy	0.000436	0.00449	CcSEcCtD
Nicotine—Muscle spasms—Lisinopril—dilated cardiomyopathy	0.000434	0.00447	CcSEcCtD
Nicotine—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.000423	0.00437	CcSEcCtD
Nicotine—Fatigue—Furosemide—dilated cardiomyopathy	0.000423	0.00436	CcSEcCtD
Nicotine—Tremor—Lisinopril—dilated cardiomyopathy	0.000423	0.00436	CcSEcCtD
Nicotine—Pain—Furosemide—dilated cardiomyopathy	0.000419	0.00432	CcSEcCtD
Nicotine—Constipation—Furosemide—dilated cardiomyopathy	0.000419	0.00432	CcSEcCtD
Nicotine—Ill-defined disorder—Lisinopril—dilated cardiomyopathy	0.000418	0.00431	CcSEcCtD
Nicotine—Angioedema—Lisinopril—dilated cardiomyopathy	0.000412	0.00425	CcSEcCtD
Nicotine—MAOB—heart—dilated cardiomyopathy	0.000411	0.0261	CbGeAlD
Nicotine—Malaise—Lisinopril—dilated cardiomyopathy	0.000407	0.00419	CcSEcCtD
Nicotine—Vertigo—Lisinopril—dilated cardiomyopathy	0.000405	0.00418	CcSEcCtD
Nicotine—Syncope—Lisinopril—dilated cardiomyopathy	0.000404	0.00417	CcSEcCtD
Nicotine—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.000404	0.00417	CcSEcCtD
Nicotine—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.000401	0.00413	CcSEcCtD
Nicotine—Palpitations—Lisinopril—dilated cardiomyopathy	0.000399	0.00411	CcSEcCtD
Nicotine—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.000396	0.00409	CcSEcCtD
Nicotine—Cough—Lisinopril—dilated cardiomyopathy	0.000394	0.00406	CcSEcCtD
Nicotine—Urticaria—Furosemide—dilated cardiomyopathy	0.00039	0.00402	CcSEcCtD
Nicotine—Body temperature increased—Furosemide—dilated cardiomyopathy	0.000388	0.004	CcSEcCtD
Nicotine—Abdominal pain—Furosemide—dilated cardiomyopathy	0.000388	0.004	CcSEcCtD
Nicotine—Chest pain—Lisinopril—dilated cardiomyopathy	0.000384	0.00396	CcSEcCtD
Nicotine—Myalgia—Lisinopril—dilated cardiomyopathy	0.000384	0.00396	CcSEcCtD
Nicotine—Arthralgia—Lisinopril—dilated cardiomyopathy	0.000384	0.00396	CcSEcCtD
Nicotine—Anxiety—Lisinopril—dilated cardiomyopathy	0.000383	0.00394	CcSEcCtD
Nicotine—Discomfort—Lisinopril—dilated cardiomyopathy	0.000379	0.00391	CcSEcCtD
Nicotine—Dry mouth—Lisinopril—dilated cardiomyopathy	0.000375	0.00387	CcSEcCtD
Nicotine—Confusional state—Lisinopril—dilated cardiomyopathy	0.000371	0.00383	CcSEcCtD
Nicotine—Oedema—Lisinopril—dilated cardiomyopathy	0.000368	0.00379	CcSEcCtD
Nicotine—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.000368	0.00379	CcSEcCtD
Nicotine—Shock—Lisinopril—dilated cardiomyopathy	0.000362	0.00373	CcSEcCtD
Nicotine—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.000361	0.00373	CcSEcCtD
Nicotine—Tachycardia—Lisinopril—dilated cardiomyopathy	0.000359	0.0037	CcSEcCtD
Nicotine—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.000356	0.00367	CcSEcCtD
Nicotine—Asthenia—Furosemide—dilated cardiomyopathy	0.000352	0.00363	CcSEcCtD
Nicotine—MAOB—cardiac atrium—dilated cardiomyopathy	0.000351	0.0223	CbGeAlD
Nicotine—MAOA—heart—dilated cardiomyopathy	0.000351	0.0223	CbGeAlD
Nicotine—Pruritus—Furosemide—dilated cardiomyopathy	0.000347	0.00358	CcSEcCtD
Nicotine—Hypotension—Lisinopril—dilated cardiomyopathy	0.000344	0.00354	CcSEcCtD
Nicotine—Diarrhoea—Furosemide—dilated cardiomyopathy	0.000336	0.00346	CcSEcCtD
Nicotine—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.000335	0.00346	CcSEcCtD
Nicotine—Insomnia—Lisinopril—dilated cardiomyopathy	0.000333	0.00343	CcSEcCtD
Nicotine—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.00033	0.00341	CcSEcCtD
Nicotine—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.000328	0.00338	CcSEcCtD
Nicotine—Somnolence—Lisinopril—dilated cardiomyopathy	0.000327	0.00337	CcSEcCtD
Nicotine—Dizziness—Furosemide—dilated cardiomyopathy	0.000324	0.00334	CcSEcCtD
Nicotine—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.000324	0.00334	CcSEcCtD
Nicotine—SLC22A5—heart—dilated cardiomyopathy	0.000323	0.0205	CbGeAlD
Nicotine—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.000318	0.00328	CcSEcCtD
Nicotine—Fatigue—Lisinopril—dilated cardiomyopathy	0.000317	0.00327	CcSEcCtD
Nicotine—Constipation—Lisinopril—dilated cardiomyopathy	0.000315	0.00324	CcSEcCtD
Nicotine—Pain—Lisinopril—dilated cardiomyopathy	0.000315	0.00324	CcSEcCtD
Nicotine—Vomiting—Furosemide—dilated cardiomyopathy	0.000312	0.00321	CcSEcCtD
Nicotine—Rash—Furosemide—dilated cardiomyopathy	0.000309	0.00319	CcSEcCtD
Nicotine—Dermatitis—Furosemide—dilated cardiomyopathy	0.000309	0.00319	CcSEcCtD
Nicotine—Headache—Furosemide—dilated cardiomyopathy	0.000307	0.00317	CcSEcCtD
Nicotine—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.000303	0.00313	CcSEcCtD
Nicotine—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.000301	0.0031	CcSEcCtD
Nicotine—MAOA—cardiac atrium—dilated cardiomyopathy	0.0003	0.019	CbGeAlD
Nicotine—Urticaria—Lisinopril—dilated cardiomyopathy	0.000292	0.00301	CcSEcCtD
Nicotine—Nausea—Furosemide—dilated cardiomyopathy	0.000291	0.003	CcSEcCtD
Nicotine—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.000291	0.003	CcSEcCtD
Nicotine—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.000291	0.003	CcSEcCtD
Nicotine—CYP1A1—heart—dilated cardiomyopathy	0.000289	0.0183	CbGeAlD
Nicotine—CYP2B6—heart—dilated cardiomyopathy	0.00028	0.0178	CbGeAlD
Nicotine—CYP2C9—heart—dilated cardiomyopathy	0.000278	0.0176	CbGeAlD
Nicotine—SLC22A5—cardiac atrium—dilated cardiomyopathy	0.000276	0.0175	CbGeAlD
Nicotine—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.000271	0.0028	CcSEcCtD
Nicotine—Asthenia—Lisinopril—dilated cardiomyopathy	0.000264	0.00272	CcSEcCtD
Nicotine—Pruritus—Lisinopril—dilated cardiomyopathy	0.00026	0.00268	CcSEcCtD
Nicotine—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.000252	0.0026	CcSEcCtD
Nicotine—CYP1A1—cardiac atrium—dilated cardiomyopathy	0.000247	0.0157	CbGeAlD
Nicotine—Dizziness—Lisinopril—dilated cardiomyopathy	0.000243	0.00251	CcSEcCtD
Nicotine—Vomiting—Lisinopril—dilated cardiomyopathy	0.000234	0.00241	CcSEcCtD
Nicotine—Rash—Lisinopril—dilated cardiomyopathy	0.000232	0.00239	CcSEcCtD
Nicotine—Dermatitis—Lisinopril—dilated cardiomyopathy	0.000232	0.00239	CcSEcCtD
Nicotine—Headache—Lisinopril—dilated cardiomyopathy	0.000231	0.00238	CcSEcCtD
Nicotine—CHRNB4—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	0.000221	0.00233	CbGpPWpGaD
Nicotine—MAOA—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.000221	0.00232	CbGpPWpGaD
Nicotine—CHAT—Metabolism—TAZ—dilated cardiomyopathy	0.000221	0.00232	CbGpPWpGaD
Nicotine—Nausea—Lisinopril—dilated cardiomyopathy	0.000219	0.00225	CcSEcCtD
Nicotine—CYP1A1—Oxidative Stress—GPX1—dilated cardiomyopathy	0.000218	0.00229	CbGpPWpGaD
Nicotine—CHRNB3—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000212	0.00223	CbGpPWpGaD
Nicotine—CYP1A2—Melatonin metabolism and effects—ADRB1—dilated cardiomyopathy	0.000208	0.00219	CbGpPWpGaD
Nicotine—CHRNB2—Circadian rythm related genes—FAS—dilated cardiomyopathy	0.000206	0.00216	CbGpPWpGaD
Nicotine—CHRNA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.000203	0.00213	CbGpPWpGaD
Nicotine—CHRNA5—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000201	0.00211	CbGpPWpGaD
Nicotine—CHAT—Metabolism—SDHA—dilated cardiomyopathy	0.0002	0.0021	CbGpPWpGaD
Nicotine—CYP2A13—Metabolism—ANKRD1—dilated cardiomyopathy	0.0002	0.0021	CbGpPWpGaD
Nicotine—CHRNA7—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	0.000192	0.00202	CbGpPWpGaD
Nicotine—CYP2A13—Metabolism—TAZ—dilated cardiomyopathy	0.000188	0.00197	CbGpPWpGaD
Nicotine—SLC22A4—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000188	0.00197	CbGpPWpGaD
Nicotine—SLC22A2—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.000187	0.00196	CbGpPWpGaD
Nicotine—CHRNA9—Neuronal System—RAF1—dilated cardiomyopathy	0.000186	0.00196	CbGpPWpGaD
Nicotine—SLC22A4—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000183	0.00192	CbGpPWpGaD
Nicotine—SLC22A4—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000183	0.00192	CbGpPWpGaD
Nicotine—CHRNA4—SIDS Susceptibility Pathways—GJA1—dilated cardiomyopathy	0.000181	0.0019	CbGpPWpGaD
Nicotine—CHRNB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.000179	0.00188	CbGpPWpGaD
Nicotine—MAOA—Neuronal System—ABCC9—dilated cardiomyopathy	0.000177	0.00186	CbGpPWpGaD
Nicotine—SLC22A1—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.000174	0.00183	CbGpPWpGaD
Nicotine—CHAT—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000171	0.0018	CbGpPWpGaD
Nicotine—SLC22A2—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.00017	0.00179	CbGpPWpGaD
Nicotine—CYP2A13—Metabolism—SDHA—dilated cardiomyopathy	0.00017	0.00178	CbGpPWpGaD
Nicotine—SLC22A4—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.00017	0.00178	CbGpPWpGaD
Nicotine—MAOA—Neuronal System—ACTN2—dilated cardiomyopathy	0.000169	0.00178	CbGpPWpGaD
Nicotine—CYP2E1—Vitamin A and Carotenoid Metabolism—CD36—dilated cardiomyopathy	0.000169	0.00177	CbGpPWpGaD
Nicotine—CHRNB3—Neuronal System—RAF1—dilated cardiomyopathy	0.000163	0.00171	CbGpPWpGaD
Nicotine—SLC22A1—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.000158	0.00166	CbGpPWpGaD
Nicotine—CHRNA4—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	0.000157	0.00165	CbGpPWpGaD
Nicotine—CHRNA5—Neuronal System—RAF1—dilated cardiomyopathy	0.000154	0.00162	CbGpPWpGaD
Nicotine—CHRNA6—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000152	0.0016	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000151	0.00159	CbGpPWpGaD
Nicotine—CYP1A1—Aryl Hydrocarbon Receptor—CD36—dilated cardiomyopathy	0.000151	0.00158	CbGpPWpGaD
Nicotine—SLC22A2—Neuronal System—ABCC9—dilated cardiomyopathy	0.000149	0.00157	CbGpPWpGaD
Nicotine—CYP1A1—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.000145	0.00152	CbGpPWpGaD
Nicotine—SLC22A2—Neuronal System—ACTN2—dilated cardiomyopathy	0.000143	0.0015	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000142	0.00149	CbGpPWpGaD
Nicotine—SLC22A3—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000142	0.00149	CbGpPWpGaD
Nicotine—SLC22A5—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000141	0.00148	CbGpPWpGaD
Nicotine—CHRNB4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.000141	0.00148	CbGpPWpGaD
Nicotine—SLC22A1—Neuronal System—ABCC9—dilated cardiomyopathy	0.000139	0.00146	CbGpPWpGaD
Nicotine—SLC22A3—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000138	0.00145	CbGpPWpGaD
Nicotine—SLC22A3—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000138	0.00145	CbGpPWpGaD
Nicotine—SLC22A5—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000137	0.00144	CbGpPWpGaD
Nicotine—CHAT—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	0.000136	0.00143	CbGpPWpGaD
Nicotine—CHRNB2—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000134	0.00141	CbGpPWpGaD
Nicotine—SLC22A1—Neuronal System—ACTN2—dilated cardiomyopathy	0.000133	0.0014	CbGpPWpGaD
Nicotine—CYP2C8—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.000133	0.0014	CbGpPWpGaD
Nicotine—CHAT—Neuronal System—RAF1—dilated cardiomyopathy	0.000131	0.00138	CbGpPWpGaD
Nicotine—CHRNA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.000129	0.00135	CbGpPWpGaD
Nicotine—SLC22A3—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000128	0.00135	CbGpPWpGaD
Nicotine—SLC22A5—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000128	0.00134	CbGpPWpGaD
Nicotine—CHRNA7—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.000122	0.00128	CbGpPWpGaD
Nicotine—CHAT—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	0.000122	0.00128	CbGpPWpGaD
Nicotine—MAOA—SIDS Susceptibility Pathways—GJA1—dilated cardiomyopathy	0.000121	0.00128	CbGpPWpGaD
Nicotine—CHAT—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	0.000119	0.00125	CbGpPWpGaD
Nicotine—CYP2C19—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.000119	0.00125	CbGpPWpGaD
Nicotine—CHRNA6—Neuronal System—RAF1—dilated cardiomyopathy	0.000117	0.00123	CbGpPWpGaD
Nicotine—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.000115	0.00121	CbGpPWpGaD
Nicotine—MAOB—Metabolism—ANKRD1—dilated cardiomyopathy	0.00011	0.00116	CbGpPWpGaD
Nicotine—CYP2C9—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.000108	0.00114	CbGpPWpGaD
Nicotine—CHRNB2—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	0.000107	0.00112	CbGpPWpGaD
Nicotine—CHAT—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	0.000107	0.00112	CbGpPWpGaD
Nicotine—CHRNB4—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000106	0.00111	CbGpPWpGaD
Nicotine—MAOA—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	0.000105	0.00111	CbGpPWpGaD
Nicotine—MAOB—Metabolism—TAZ—dilated cardiomyopathy	0.000103	0.00109	CbGpPWpGaD
Nicotine—CHRNB2—Neuronal System—RAF1—dilated cardiomyopathy	0.000103	0.00108	CbGpPWpGaD
Nicotine—CHRNA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	9.95e-05	0.00105	CbGpPWpGaD
Nicotine—CHRNA3—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	9.67e-05	0.00102	CbGpPWpGaD
Nicotine—CYP1A2—Aryl Hydrocarbon Receptor—CD36—dilated cardiomyopathy	9.61e-05	0.00101	CbGpPWpGaD
Nicotine—CYP1A1—Aryl Hydrocarbon Receptor—RAF1—dilated cardiomyopathy	9.42e-05	0.00099	CbGpPWpGaD
Nicotine—MAOB—Metabolism—SDHA—dilated cardiomyopathy	9.35e-05	0.000983	CbGpPWpGaD
Nicotine—SLC22A3—Metabolism—ANKRD1—dilated cardiomyopathy	9.3e-05	0.000978	CbGpPWpGaD
Nicotine—CYP19A1—Integrated Breast Cancer Pathway—RAC1—dilated cardiomyopathy	9.26e-05	0.000973	CbGpPWpGaD
Nicotine—CYP1A2—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	9.23e-05	0.000971	CbGpPWpGaD
Nicotine—CHRNA7—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	9.17e-05	0.000964	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	8.96e-05	0.000942	CbGpPWpGaD
Nicotine—SLC22A2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	8.88e-05	0.000933	CbGpPWpGaD
Nicotine—SLC22A3—Metabolism—TAZ—dilated cardiomyopathy	8.75e-05	0.000919	CbGpPWpGaD
Nicotine—SLC22A2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	8.63e-05	0.000908	CbGpPWpGaD
Nicotine—SLC22A2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	8.63e-05	0.000908	CbGpPWpGaD
Nicotine—CHRNA2—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	8.62e-05	0.000907	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	8.43e-05	0.000886	CbGpPWpGaD
Nicotine—CHRNB4—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	8.42e-05	0.000885	CbGpPWpGaD
Nicotine—SLC22A1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	8.27e-05	0.00087	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	8.22e-05	0.000864	CbGpPWpGaD
Nicotine—CHRNB4—Neuronal System—RAF1—dilated cardiomyopathy	8.1e-05	0.000851	CbGpPWpGaD
Nicotine—SLC22A1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	8.05e-05	0.000846	CbGpPWpGaD
Nicotine—SLC22A1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	8.05e-05	0.000846	CbGpPWpGaD
Nicotine—SLC22A2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	8.03e-05	0.000844	CbGpPWpGaD
Nicotine—SLC22A3—Metabolism—SDHA—dilated cardiomyopathy	7.91e-05	0.000831	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	7.72e-05	0.000812	CbGpPWpGaD
Nicotine—CYP1A1—PPARA activates gene expression—CD36—dilated cardiomyopathy	7.51e-05	0.000789	CbGpPWpGaD
Nicotine—SLC22A1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	7.48e-05	0.000786	CbGpPWpGaD
Nicotine—CHRNA4—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	7.48e-05	0.000786	CbGpPWpGaD
Nicotine—CHRNA3—Neuronal System—RAF1—dilated cardiomyopathy	7.41e-05	0.000779	CbGpPWpGaD
Nicotine—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CD36—dilated cardiomyopathy	7.35e-05	0.000772	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	7.33e-05	0.000771	CbGpPWpGaD
Nicotine—CHRNA7—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	7.31e-05	0.000768	CbGpPWpGaD
Nicotine—CHRNA7—Neuronal System—RAF1—dilated cardiomyopathy	7.03e-05	0.000739	CbGpPWpGaD
Nicotine—MAOA—Metabolism—ANKRD1—dilated cardiomyopathy	6.9e-05	0.000725	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	6.89e-05	0.000725	CbGpPWpGaD
Nicotine—CYP1A1—PPARA activates gene expression—AGT—dilated cardiomyopathy	6.76e-05	0.00071	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism—ANKRD1—dilated cardiomyopathy	6.73e-05	0.000707	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	6.69e-05	0.000703	CbGpPWpGaD
Nicotine—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—AGT—dilated cardiomyopathy	6.61e-05	0.000695	CbGpPWpGaD
Nicotine—CHRNA2—Neuronal System—RAF1—dilated cardiomyopathy	6.61e-05	0.000695	CbGpPWpGaD
Nicotine—MAOA—Metabolism—TAZ—dilated cardiomyopathy	6.49e-05	0.000682	CbGpPWpGaD
Nicotine—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—dilated cardiomyopathy	6.46e-05	0.000679	CbGpPWpGaD
Nicotine—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—dilated cardiomyopathy	6.46e-05	0.000679	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism—TAZ—dilated cardiomyopathy	6.33e-05	0.000665	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	6.29e-05	0.000661	CbGpPWpGaD
Nicotine—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—dilated cardiomyopathy	6.15e-05	0.000647	CbGpPWpGaD
Nicotine—CYP1A1—Aryl Hydrocarbon Receptor—TNF—dilated cardiomyopathy	6.15e-05	0.000647	CbGpPWpGaD
Nicotine—CYP1A2—Aryl Hydrocarbon Receptor—RAF1—dilated cardiomyopathy	6.01e-05	0.000631	CbGpPWpGaD
Nicotine—CHRNA4—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	5.96e-05	0.000626	CbGpPWpGaD
Nicotine—MAOA—Metabolism—SDHA—dilated cardiomyopathy	5.87e-05	0.000617	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—ANKRD1—dilated cardiomyopathy	5.83e-05	0.000613	CbGpPWpGaD
Nicotine—CHRNA4—Neuronal System—RAF1—dilated cardiomyopathy	5.73e-05	0.000602	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism—SDHA—dilated cardiomyopathy	5.72e-05	0.000601	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	5.71e-05	0.000601	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—TAZ—dilated cardiomyopathy	5.49e-05	0.000577	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—ANKRD1—dilated cardiomyopathy	5.44e-05	0.000572	CbGpPWpGaD
Nicotine—CHAT—Metabolism—GPX1—dilated cardiomyopathy	5.42e-05	0.00057	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	5.37e-05	0.000565	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—ANKRD1—dilated cardiomyopathy	5.36e-05	0.000563	CbGpPWpGaD
Nicotine—CHAT—Metabolism—CD36—dilated cardiomyopathy	5.28e-05	0.000555	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—TAZ—dilated cardiomyopathy	5.11e-05	0.000537	CbGpPWpGaD
Nicotine—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CD36—dilated cardiomyopathy	5.06e-05	0.000532	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—TAZ—dilated cardiomyopathy	5.04e-05	0.000529	CbGpPWpGaD
Nicotine—MAOA—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	5.03e-05	0.000528	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—SDHA—dilated cardiomyopathy	4.96e-05	0.000521	CbGpPWpGaD
Nicotine—CHAT—Metabolism—AGT—dilated cardiomyopathy	4.76e-05	0.0005	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—SDHA—dilated cardiomyopathy	4.62e-05	0.000486	CbGpPWpGaD
Nicotine—CYP2A13—Metabolism—GPX1—dilated cardiomyopathy	4.61e-05	0.000485	CbGpPWpGaD
Nicotine—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—AGT—dilated cardiomyopathy	4.56e-05	0.000479	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—SDHA—dilated cardiomyopathy	4.55e-05	0.000479	CbGpPWpGaD
Nicotine—CYP2A13—Metabolism—CD36—dilated cardiomyopathy	4.49e-05	0.000472	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—ANKRD1—dilated cardiomyopathy	4.32e-05	0.000454	CbGpPWpGaD
Nicotine—SLC22A2—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	4.25e-05	0.000447	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—ANKRD1—dilated cardiomyopathy	4.23e-05	0.000445	CbGpPWpGaD
Nicotine—CYP19A1—Integrated Breast Cancer Pathway—EGFR—dilated cardiomyopathy	4.21e-05	0.000442	CbGpPWpGaD
Nicotine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—dilated cardiomyopathy	4.12e-05	0.000433	CbGpPWpGaD
Nicotine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—dilated cardiomyopathy	4.12e-05	0.000433	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—TAZ—dilated cardiomyopathy	4.06e-05	0.000427	CbGpPWpGaD
Nicotine—CYP2A13—Metabolism—AGT—dilated cardiomyopathy	4.04e-05	0.000425	CbGpPWpGaD
Nicotine—MAOA—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	4e-05	0.000421	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—ANKRD1—dilated cardiomyopathy	3.99e-05	0.000419	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—TAZ—dilated cardiomyopathy	3.98e-05	0.000418	CbGpPWpGaD
Nicotine—SLC22A1—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	3.96e-05	0.000416	CbGpPWpGaD
Nicotine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—dilated cardiomyopathy	3.92e-05	0.000412	CbGpPWpGaD
Nicotine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—dilated cardiomyopathy	3.92e-05	0.000412	CbGpPWpGaD
Nicotine—MAOA—Neuronal System—RAF1—dilated cardiomyopathy	3.85e-05	0.000405	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—TAZ—dilated cardiomyopathy	3.75e-05	0.000394	CbGpPWpGaD
Nicotine—SLC22A4—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	3.7e-05	0.000389	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—SDHA—dilated cardiomyopathy	3.67e-05	0.000386	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—ANKRD1—dilated cardiomyopathy	3.66e-05	0.000385	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—SDHA—dilated cardiomyopathy	3.6e-05	0.000378	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	3.49e-05	0.000367	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—TAZ—dilated cardiomyopathy	3.44e-05	0.000362	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	3.4e-05	0.000357	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—SDHA—dilated cardiomyopathy	3.39e-05	0.000357	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—ANKRD1—dilated cardiomyopathy	3.27e-05	0.000343	CbGpPWpGaD
Nicotine—SLC22A2—Neuronal System—RAF1—dilated cardiomyopathy	3.26e-05	0.000342	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—SDHA—dilated cardiomyopathy	3.11e-05	0.000327	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—TAZ—dilated cardiomyopathy	3.07e-05	0.000323	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	3.06e-05	0.000322	CbGpPWpGaD
Nicotine—SLC22A1—Neuronal System—RAF1—dilated cardiomyopathy	3.04e-05	0.000319	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—ANKRD1—dilated cardiomyopathy	3e-05	0.000316	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—ANKRD1—dilated cardiomyopathy	2.98e-05	0.000313	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—TAZ—dilated cardiomyopathy	2.82e-05	0.000297	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—TAZ—dilated cardiomyopathy	2.8e-05	0.000294	CbGpPWpGaD
Nicotine—SLC22A3—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	2.79e-05	0.000293	CbGpPWpGaD
Nicotine—SLC22A5—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	2.78e-05	0.000292	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—SDHA—dilated cardiomyopathy	2.78e-05	0.000292	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—SDHA—dilated cardiomyopathy	2.55e-05	0.000268	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—ANKRD1—dilated cardiomyopathy	2.54e-05	0.000267	CbGpPWpGaD
Nicotine—MAOB—Metabolism—GPX1—dilated cardiomyopathy	2.54e-05	0.000267	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—SDHA—dilated cardiomyopathy	2.53e-05	0.000266	CbGpPWpGaD
Nicotine—MAOB—Metabolism—CD36—dilated cardiomyopathy	2.47e-05	0.00026	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—TAZ—dilated cardiomyopathy	2.39e-05	0.000251	CbGpPWpGaD
Nicotine—MAOB—Metabolism—AGT—dilated cardiomyopathy	2.23e-05	0.000234	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—SDHA—dilated cardiomyopathy	2.16e-05	0.000227	CbGpPWpGaD
Nicotine—SLC22A3—Metabolism—GPX1—dilated cardiomyopathy	2.15e-05	0.000226	CbGpPWpGaD
Nicotine—SLC22A3—Metabolism—CD36—dilated cardiomyopathy	2.09e-05	0.00022	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	2.07e-05	0.000218	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	2.02e-05	0.000212	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—ANKRD1—dilated cardiomyopathy	1.96e-05	0.000206	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	1.9e-05	0.000199	CbGpPWpGaD
Nicotine—SLC22A3—Metabolism—AGT—dilated cardiomyopathy	1.88e-05	0.000198	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	1.85e-05	0.000194	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—TAZ—dilated cardiomyopathy	1.85e-05	0.000194	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	1.81e-05	0.000191	CbGpPWpGaD
Nicotine—SLC22A2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.75e-05	0.000184	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	1.69e-05	0.000178	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—SDHA—dilated cardiomyopathy	1.67e-05	0.000176	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	1.66e-05	0.000175	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	1.65e-05	0.000173	CbGpPWpGaD
Nicotine—SLC22A1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.63e-05	0.000172	CbGpPWpGaD
Nicotine—MAOA—Metabolism—GPX1—dilated cardiomyopathy	1.59e-05	0.000168	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism—GPX1—dilated cardiomyopathy	1.55e-05	0.000163	CbGpPWpGaD
Nicotine—MAOA—Metabolism—CD36—dilated cardiomyopathy	1.55e-05	0.000163	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	1.54e-05	0.000162	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism—CD36—dilated cardiomyopathy	1.51e-05	0.000159	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	1.5e-05	0.000158	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	1.49e-05	0.000156	CbGpPWpGaD
Nicotine—MAOA—Metabolism—AGT—dilated cardiomyopathy	1.4e-05	0.000147	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism—AGT—dilated cardiomyopathy	1.36e-05	0.000143	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	1.35e-05	0.000142	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—GPX1—dilated cardiomyopathy	1.35e-05	0.000142	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	1.32e-05	0.000139	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—CD36—dilated cardiomyopathy	1.31e-05	0.000138	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	1.29e-05	0.000135	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—GPX1—dilated cardiomyopathy	1.26e-05	0.000132	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—GPX1—dilated cardiomyopathy	1.24e-05	0.00013	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—CD36—dilated cardiomyopathy	1.22e-05	0.000129	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—CD36—dilated cardiomyopathy	1.2e-05	0.000127	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—AGT—dilated cardiomyopathy	1.18e-05	0.000124	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	1.16e-05	0.000122	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—AGT—dilated cardiomyopathy	1.1e-05	0.000116	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—AGT—dilated cardiomyopathy	1.08e-05	0.000114	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—GPX1—dilated cardiomyopathy	9.98e-06	0.000105	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—GPX1—dilated cardiomyopathy	9.78e-06	0.000103	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—CD36—dilated cardiomyopathy	9.72e-06	0.000102	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—CD36—dilated cardiomyopathy	9.52e-06	0.0001	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—GPX1—dilated cardiomyopathy	9.22e-06	9.69e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—CD36—dilated cardiomyopathy	8.98e-06	9.44e-05	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—AGT—dilated cardiomyopathy	8.75e-06	9.2e-05	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—AGT—dilated cardiomyopathy	8.57e-06	9.01e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—GPX1—dilated cardiomyopathy	8.45e-06	8.88e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—CD36—dilated cardiomyopathy	8.23e-06	8.65e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—AGT—dilated cardiomyopathy	8.08e-06	8.5e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—GPX1—dilated cardiomyopathy	7.54e-06	7.93e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—AGT—dilated cardiomyopathy	7.41e-06	7.79e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—CD36—dilated cardiomyopathy	7.35e-06	7.72e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—GPX1—dilated cardiomyopathy	6.94e-06	7.29e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—GPX1—dilated cardiomyopathy	6.88e-06	7.23e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—CD36—dilated cardiomyopathy	6.76e-06	7.1e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—CD36—dilated cardiomyopathy	6.7e-06	7.04e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—AGT—dilated cardiomyopathy	6.61e-06	6.95e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—AGT—dilated cardiomyopathy	6.08e-06	6.39e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—AGT—dilated cardiomyopathy	6.03e-06	6.34e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—GPX1—dilated cardiomyopathy	5.88e-06	6.18e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—CD36—dilated cardiomyopathy	5.72e-06	6.02e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—AGT—dilated cardiomyopathy	5.15e-06	5.42e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—GPX1—dilated cardiomyopathy	4.54e-06	4.77e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—CD36—dilated cardiomyopathy	4.42e-06	4.64e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—AGT—dilated cardiomyopathy	3.98e-06	4.18e-05	CbGpPWpGaD
